FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1961648385> ?p ?o ?g. }

• W1961648385 endingPage "e0004151" @default.
• W1961648385 startingPage "e0004151" @default.
• W1961648385 abstract "Background Scabies is endemic in many Aboriginal and Torres Strait Islander communities, with 69% of infants infected in the first year of life. We report the outcomes against scabies of two oral ivermectin mass drug administrations (MDAs) delivered 12 months apart in a remote Australian Aboriginal community. Methods Utilizing a before and after study design, we measured scabies prevalence through population census with sequential MDAs at baseline and month 12. Surveys at months 6 and 18 determined disease acquisition and treatment failures. Scabies infestations were diagnosed clinically with additional laboratory investigations for crusted scabies. Non-pregnant participants weighing ≥15 kg were administered a single 200 μg/kg ivermectin dose, repeated after 2–3 weeks if scabies was diagnosed, others followed a standard alternative algorithm. Principal Findings We saw >1000 participants at each population census. Scabies prevalence fell from 4% at baseline to 1% at month 6. Prevalence rose to 9% at month 12 amongst the baseline cohort in association with an identified exposure to a presumptive crusted scabies case with a higher prevalence of 14% amongst new entries to the cohort. At month 18, scabies prevalence fell to 2%. Scabies acquisitions six months after each MDA were 1% and 2% whilst treatment failures were 6% and 5% respectively. Conclusion Scabies prevalence reduced in the six months after each MDA with a low risk of acquisition (1–2%). However, in a setting where living conditions are conducive to high scabies transmissibility, exposure to presumptive crusted scabies and population mobility, a sustained reduction in prevalence was not achieved. Clinical Trial Registration Australian New Zealand Clinical Trial Register (ACTRN—12609000654257)." @default.
• W1961648385 created "2016-06-24" @default.
• W1961648385 creator A5023976277 @default.
• W1961648385 creator A5029737926 @default.
• W1961648385 creator A5031956134 @default.
• W1961648385 creator A5037170976 @default.
• W1961648385 creator A5050798377 @default.
• W1961648385 creator A5055957305 @default.
• W1961648385 creator A5058227593 @default.
• W1961648385 creator A5063649007 @default.
• W1961648385 creator A5066311181 @default.
• W1961648385 creator A5068058892 @default.
• W1961648385 creator A5068619911 @default.
• W1961648385 creator A5069401929 @default.
• W1961648385 creator A5079870912 @default.
• W1961648385 creator A5090496242 @default.
• W1961648385 date "2015-10-30" @default.
• W1961648385 modified "2023-10-15" @default.
• W1961648385 title "Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community" @default.
• W1961648385 cites W1498238503 @default.
• W1961648385 cites W1841125810 @default.
• W1961648385 cites W1890387170 @default.
• W1961648385 cites W1892746564 @default.
• W1961648385 cites W1964081449 @default.
• W1961648385 cites W1969738950 @default.
• W1961648385 cites W1974260500 @default.
• W1961648385 cites W2008372760 @default.
• W1961648385 cites W2019881923 @default.
• W1961648385 cites W2055730579 @default.
• W1961648385 cites W2068161382 @default.
• W1961648385 cites W2069939490 @default.
• W1961648385 cites W2070570959 @default.
• W1961648385 cites W2077955949 @default.
• W1961648385 cites W2089953642 @default.
• W1961648385 cites W2093349806 @default.
• W1961648385 cites W2112570386 @default.
• W1961648385 cites W2125779260 @default.
• W1961648385 cites W2133348795 @default.
• W1961648385 cites W2134545014 @default.
• W1961648385 cites W2134561148 @default.
• W1961648385 cites W2135085388 @default.
• W1961648385 cites W2151810774 @default.
• W1961648385 cites W2160055163 @default.
• W1961648385 cites W2162950025 @default.
• W1961648385 cites W2397618469 @default.
• W1961648385 cites W2403471879 @default.
• W1961648385 doi "https://doi.org/10.1371/journal.pntd.0004151" @default.
• W1961648385 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4627839" @default.
• W1961648385 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26516764" @default.
• W1961648385 hasPublicationYear "2015" @default.
• W1961648385 type Work @default.
• W1961648385 sameAs 1961648385 @default.
• W1961648385 citedByCount "75" @default.
• W1961648385 countsByYear W19616483852016 @default.
• W1961648385 countsByYear W19616483852017 @default.
• W1961648385 countsByYear W19616483852018 @default.
• W1961648385 countsByYear W19616483852019 @default.
• W1961648385 countsByYear W19616483852020 @default.
• W1961648385 countsByYear W19616483852021 @default.
• W1961648385 countsByYear W19616483852022 @default.
• W1961648385 countsByYear W19616483852023 @default.
• W1961648385 crossrefType "journal-article" @default.
• W1961648385 hasAuthorship W1961648385A5023976277 @default.
• W1961648385 hasAuthorship W1961648385A5029737926 @default.
• W1961648385 hasAuthorship W1961648385A5031956134 @default.
• W1961648385 hasAuthorship W1961648385A5037170976 @default.
• W1961648385 hasAuthorship W1961648385A5050798377 @default.
• W1961648385 hasAuthorship W1961648385A5055957305 @default.
• W1961648385 hasAuthorship W1961648385A5058227593 @default.
• W1961648385 hasAuthorship W1961648385A5063649007 @default.
• W1961648385 hasAuthorship W1961648385A5066311181 @default.
• W1961648385 hasAuthorship W1961648385A5068058892 @default.
• W1961648385 hasAuthorship W1961648385A5068619911 @default.
• W1961648385 hasAuthorship W1961648385A5069401929 @default.
• W1961648385 hasAuthorship W1961648385A5079870912 @default.
• W1961648385 hasAuthorship W1961648385A5090496242 @default.
• W1961648385 hasBestOaLocation W19616483851 @default.
• W1961648385 hasConcept C126322002 @default.
• W1961648385 hasConcept C16005928 @default.
• W1961648385 hasConcept C2777499811 @default.
• W1961648385 hasConcept C2781443149 @default.
• W1961648385 hasConcept C2908647359 @default.
• W1961648385 hasConcept C42972112 @default.
• W1961648385 hasConcept C71924100 @default.
• W1961648385 hasConcept C72563966 @default.
• W1961648385 hasConcept C99454951 @default.
• W1961648385 hasConceptScore W1961648385C126322002 @default.
• W1961648385 hasConceptScore W1961648385C16005928 @default.
• W1961648385 hasConceptScore W1961648385C2777499811 @default.
• W1961648385 hasConceptScore W1961648385C2781443149 @default.
• W1961648385 hasConceptScore W1961648385C2908647359 @default.
• W1961648385 hasConceptScore W1961648385C42972112 @default.
• W1961648385 hasConceptScore W1961648385C71924100 @default.
• W1961648385 hasConceptScore W1961648385C72563966 @default.
• W1961648385 hasConceptScore W1961648385C99454951 @default.
• W1961648385 hasIssue "10" @default.
• W1961648385 hasLocation W19616483851 @default.
• W1961648385 hasLocation W19616483852 @default.

• next